Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing
Av Harry Yang, 2016.Del av serien Chapman & Hall/CRC Biostatistics Series.
The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.
Ikke tilgjengelig for Klikk&Hent
Midlertidig tomt på lager
Bestillingsvare. Forventes sendt om ca 11 dager
Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing
Av Harry Yang, 2016.Del av serien Chapman & Hall/CRC Biostatistics Series.
The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.
Ikke tilgjengelig for Klikk&Hent
Midlertidig tomt på lager
Bestillingsvare. Forventes sendt om ca 11 dager
Ved å fullføre kjøpet aksepterer du kjøpsvilkårene.
